NO883468D0 - Fremgangsmaate til fremstilling av farmasoeytiske blandinger inneholdende cyklopeptider som reserpsjonsbefordrere ved applikasjon paa slimhuden. - Google Patents

Fremgangsmaate til fremstilling av farmasoeytiske blandinger inneholdende cyklopeptider som reserpsjonsbefordrere ved applikasjon paa slimhuden.

Info

Publication number
NO883468D0
NO883468D0 NO883468A NO883468A NO883468D0 NO 883468 D0 NO883468 D0 NO 883468D0 NO 883468 A NO883468 A NO 883468A NO 883468 A NO883468 A NO 883468A NO 883468 D0 NO883468 D0 NO 883468D0
Authority
NO
Norway
Prior art keywords
denotes
amino acid
slim
reservation
processors
Prior art date
Application number
NO883468A
Other languages
English (en)
Other versions
NO883468L (no
NO179094C (no
NO179094B (no
Inventor
Jurgen Kurt Sandow
Rainer Schmiedel
Klaus Wirth
Hans Peter Merkle
Susanne Raehs
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO883468D0 publication Critical patent/NO883468D0/no
Publication of NO883468L publication Critical patent/NO883468L/no
Publication of NO179094B publication Critical patent/NO179094B/no
Publication of NO179094C publication Critical patent/NO179094C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO883468A 1987-08-07 1988-08-04 Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen NO179094C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873726324 DE3726324A1 (de) 1987-08-07 1987-08-07 Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute

Publications (4)

Publication Number Publication Date
NO883468D0 true NO883468D0 (no) 1988-08-04
NO883468L NO883468L (no) 1989-02-08
NO179094B NO179094B (no) 1996-04-29
NO179094C NO179094C (no) 1996-08-07

Family

ID=6333298

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883468A NO179094C (no) 1987-08-07 1988-08-04 Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen

Country Status (19)

Country Link
US (1) US5091365A (no)
EP (1) EP0302466B1 (no)
JP (1) JP2764930B2 (no)
KR (1) KR970004039B1 (no)
AT (1) ATE69556T1 (no)
AU (1) AU608878B2 (no)
CA (1) CA1331131C (no)
DE (2) DE3726324A1 (no)
DK (1) DK168273B1 (no)
ES (1) ES2038725T3 (no)
FI (1) FI883643A (no)
GR (1) GR3003733T3 (no)
HU (1) HU199301B (no)
IE (1) IE60871B1 (no)
IL (1) IL87362A0 (no)
NO (1) NO179094C (no)
NZ (1) NZ225715A (no)
PT (1) PT88192B (no)
ZA (1) ZA885724B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW274552B (no) * 1992-05-26 1996-04-21 Hoechst Ag
PT710243E (pt) * 1993-06-29 2000-11-30 Ferring Bv Sintese melhorada de peptidos ciclicos.
US5767068A (en) * 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
IT1294191B1 (it) * 1997-09-05 1999-03-22 Alfa Wassermann Spa Composizioni farmaceutiche contenenti calcitonina in un dosatore spray per somministrazione intranasale.
KR100611559B1 (ko) * 1998-05-08 2007-04-25 동아제약주식회사 칼시토닌을 함유한 비강투여용 약제학적 조성물
SE514606C2 (sv) * 1998-08-26 2001-03-19 Laekartjaenster I Vaestsverige Läkemedel innehållande GnRH-analoger för behandling av schizofreni
DE10014007A1 (de) * 2000-03-22 2001-10-11 Strathmann Ag & Co Neue Darreichungsformen für DSIP
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
WO2004084859A2 (en) 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
US9988428B2 (en) 2016-04-19 2018-06-05 Griffon Pharmaceuticals Inc. Pegylated bioactive peptides and uses thereof
US20220226479A1 (en) * 2019-03-25 2022-07-21 University Of Tsukuba Cell layer permeation promoter. composition for facilitating drug absorption. and pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3171774D1 (en) * 1980-03-31 1985-09-19 Teijin Ltd Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS58140026A (ja) * 1982-01-14 1983-08-19 Toyo Jozo Co Ltd 吸収性良好な製剤
CA1188987A (en) * 1981-03-06 1985-06-18 Masataka Morishita Preparation having excellent absorption property
US4568665A (en) 1982-06-25 1986-02-04 Mitchell David C Protein compounds
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
DE3532074A1 (de) * 1985-09-09 1987-03-12 Berlin Chemie Veb Resorptionsvermittler fuer biologisch aktive peptide

Also Published As

Publication number Publication date
ES2038725T3 (es) 1993-08-01
DE3726324A1 (de) 1989-02-16
NO883468L (no) 1989-02-08
DK440888D0 (da) 1988-08-05
HUT47599A (en) 1989-03-28
KR890003409A (ko) 1989-04-14
DE3866307D1 (de) 1992-01-02
EP0302466A1 (de) 1989-02-08
HU199301B (en) 1990-02-28
NO179094C (no) 1996-08-07
IE882408L (en) 1989-02-07
JP2764930B2 (ja) 1998-06-11
US5091365A (en) 1992-02-25
FI883643A (fi) 1989-02-08
JPS6466128A (en) 1989-03-13
PT88192A (pt) 1989-06-30
NO179094B (no) 1996-04-29
FI883643A0 (fi) 1988-08-04
DK440888A (da) 1989-02-08
IL87362A0 (en) 1989-01-31
AU608878B2 (en) 1991-04-18
ZA885724B (en) 1989-04-26
PT88192B (pt) 1995-03-01
ATE69556T1 (de) 1991-12-15
IE60871B1 (en) 1994-08-24
DK168273B1 (da) 1994-03-07
EP0302466B1 (de) 1991-11-21
CA1331131C (en) 1994-08-02
GR3003733T3 (no) 1993-03-16
AU2043388A (en) 1989-04-20
KR970004039B1 (ko) 1997-03-24
NZ225715A (en) 1991-02-26

Similar Documents

Publication Publication Date Title
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
DE68903846T2 (de) Neue galenische form von fenofibrat.
ES520226A0 (es) Procedimiento para la preparacion de derivados de cefem.
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
NO883073L (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate for fremstilling av dem, farmasoeytiske preparater paa basis av disse forbindelsene, deres anvendelse saavel som mellomprodukter.
NO883468D0 (no) Fremgangsmaate til fremstilling av farmasoeytiske blandinger inneholdende cyklopeptider som reserpsjonsbefordrere ved applikasjon paa slimhuden.
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
ATE101153T1 (de) Thiazolopyrimidinderivate als angiotensin-iirezeptorantagonisten: verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
IE894050L (en) Compound with gastric acid inhibitory effect and process for¹its preparation
DK408083A (da) Isoquinolinderivater, deres fremstilling og anvendelse
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
EA199900226A1 (ru) Фармацевтические композиции для лечения вирусных заболеваний
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
ES2072270T3 (es) Agente farmaceutico administrable por via oral, especialmente para la terapia de substitucion de hierro y de magnesio.
MX9303074A (es) Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer.
DK248987D0 (da) Farmaceutiske praeparater til forbedring af sammensaetningen af lipider i blod
SE8603517D0 (sv) Heterocyclic compounds and their preparation and pharmaceutical formulation
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
NO823682L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridazinonimin-derivater.
IT1259140B (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2002